Alliance News South Africa Professional
GSK lifts sales and profit outlook as Specialty Medicines unit shines
(Alliance News) - GSK PLC on Wednesday raised guidance after a strong third quarter, which saw sales in all three divisions beat expectations. ...
Read more
Glencore tightens 2025 guidance after strong third-quarter performance
(Alliance News) - Glencore PLC reported on Wednesday it had tightened its annual production guidance after delivering "strong" performance for the first nine months of this year. ...
Read more
LONDON BRIEFING: GSK ups 2025 outlook; Next sales beat guidance
(Alliance News) - GSK raises its outlook for revenue and profit, Next ups its guidance as third quarter sales beat expectations, while Primary Health Properties' acquisition of Assura is cleared...
Read more
LONDON MARKET EARLY CALL: FTSE 100 seen flat after record close
(Alliance News) - Stocks in London are set to open marginally lower on Wednesday, following a record close on Tuesday, ahead of a swathe of earnings reports and interest rate...
Read more
UK can "defy" gloomy forecasts despite productivity problems — Reeves
(Alliance News) - Britain does not have to "accept" grim economic forecasts, Rachel Reeves has insisted despite reports she faces a barrage of fiscal bad news ahead of next month's...
Read more
LONDON MARKET CLOSE: FTSE 100 hits new best ahead of Fed, tech results
(Alliance News) - The FTSE 100 recorded another record high on Tuesday boosted by HSBC, while Wall Street made further gains ahead of key tech earnings and central bank meetings....
Read more
LONDON MARKET MIDDAY: FTSE 100 reaches new record as Airtel impresses
(Alliance News) - Stock prices in London were mixed at midday on Tuesday, as the FTSE 100 hit a new record but the FTSE 250 index underperformed....
Read more
Valterra production falls after nine months as recovery continues
(Alliance News) - Valterra Platinum Ltd on Tuesday reported lower production for the first nine months of 2025 as it continued to recover from floods that hit a key mine...
Read more
AstraZeneca hails EU approval of Koselugo for form of neurofibromas
(Alliance News) - AstraZeneca PLC on Tuesday said Alexion's selective inhibitor Koseluga has been approved in the EU for the treatment of symptomatic, inoperable plexiform neurofibromas, PN, in adult patients...
Read more
GSK strikes license deal with Empirico; gets cancer drug designation
(Alliance News) - GSK on Tuesday said it will pay up to USD745 million, plus royalties, as part of a license deal with US biotechnology company Empirico Inc. ...
Read more